Clinical trial Phase 3 Interventional Ages 18 to 85

Clinical Trial of Vormatrigine in Adult Patients With Epilepsy

Run by Praxis Precision Medicines · NCT07287163 · Data updated 2026-11-12

Enrolling by invitation only. This study is not taking new participants. Its registered completion date is 2028-05-31.

Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy

Research outlook What's coming for Epilepsy: the next 6 months to 5 years

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment700 (estimated)
SponsorPraxis Precision Medicines
Industry-sponsored
Drugs / interventionsvormatrogine
Locations36 sites (Brazil, Germany, Italy, Poland, Spain, United States)
Trial IDNCT07287163 on ClinicalTrials.gov

What this trial studies

An open label extension clinical trial to assess the safety and tolerability of vormatrigine in adults with focal or primary generalized tonic-clonic seizures.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participant who completed an eligible clinical trial (unless agreed by the sponsor medical monitor), including PRAX-628-212, PRAX-628-321 or other vormatrigine trials, or participant who has received vormatrigine outside of an eligible clinical trial (such as an expanded access program)
* Participant who had adequate seizure diary and vormatrigine adherence and had been otherwise adherent to the study procedures in the opinion of the investigator unless deemed unacceptable by sponsor

Exclusion Criteria:

* Participant who withdrew or discontinued treatment from the treatment period of an eligible clinical trial unless deemed acceptable by the sponsor
* Participant who plans to enter another interventional investigational study or is on any prohibited medication
* Participant who is pregnant, lactating or planning to become pregnant
* Participant who is ineligible for the extension clinical trial in the view of the investigator

Where it's running

  • Praxis Research Site
    Miami, Florida, United States
  • Praxis Research Site
    Miami Lakes, Florida, United States
  • Praxis Research Site
    Naples, Florida, United States
  • Praxis Research Site
    Lafayette, Louisiana, United States
  • Praxis Research Site
    Bethesda, Maryland, United States
  • Praxis Research Site
    Plymouth, Michigan, United States
Show 30 more locations
  • Praxis Research Site
    Chesterfield, Missouri, United States
  • Praxis Research Site
    Hackensack, New Jersey, United States
  • Praxis Research Site
    Amherst, New York, United States
  • Praxis Research Site
    Middletown, New York, United States
  • Praxis Research Site
    New York, New York, United States
  • Praxis Research Site
    Niagara Falls, New York, United States
  • Praxis Research Site
    Philadelphia, Pennsylvania, United States
  • Praxis Research Site
    El Paso, Texas, United States
  • Praxis Research Site
    Houston, Texas, United States
  • Praxis Research Site
    Porto Alegre, Rio Grande do Sul, Brazil
  • Praxis Research Site
    São José do Rio Preto, São Paulo, Brazil
  • Praxis Research Site
    Bielefeld, Germany
  • Praxis Research Site
    Tübingen, Germany
  • Praxis Research Site
    Pozzilli, Isernia, Italy
  • Praxis Research Site
    Bosisio Parini, Lecco, Italy
  • Praxis Research Site
    Milan, Italy
  • Praxis Research Site
    Naples, Italy
  • Praxis Research Site
    Pavia, Italy
  • Praxis Research Site
    Pisa, Italy
  • Praxis Research Site
    Ponderano, Italy
  • Praxis Research Site
    Roma, Italy
  • Praxis Research Site
    Bydgoszcz, Poland
  • Praxis Research Site
    Katowice, Poland
  • Praxis Research Site
    Lublin, Poland
  • Praxis Research Site
    Warsaw, Poland
  • Praxis Research Site
    Barcelona, Spain
  • Praxis Research Site
    Madrid, Spain
  • Praxis Research Site
    Málaga, Spain
  • Praxis Research Site
    Terrassa, Spain
  • Praxis Research Site
    Valencia, Spain

Study contacts

  • Principal investigator: Medical Director — Praxis Precision Medicines

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.